These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30053818)

  • 41. Carboxyl-terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activity.
    Chen YQ; Yang Y; Zhen EY; Beyer TP; Li H; Wen Y; Ehsani M; Jackson N; Xie K; Jung H; Scheithauer JL; Kumari A; Birrane G; Russell AM; Balasubramaniam D; Liao Z; Siegel RW; Qian Y; Ploug M; Young SG; Konrad RJ
    Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2322332121. PubMed ID: 38625948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants.
    Grosskopf I; Baroukh N; Lee SJ; Kamari Y; Harats D; Rubin EM; Pennacchio LA; Cooper AD
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2573-9. PubMed ID: 16166565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical significance of apolipoprotein A5.
    Tai ES; Ordovas JM
    Curr Opin Lipidol; 2008 Aug; 19(4):349-54. PubMed ID: 18607181
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
    Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
    Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apoprotein A-V: an important regulator of triglyceride metabolism.
    Kluger M; Heeren J; Merkel M
    J Inherit Metab Dis; 2008 Apr; 31(2):281-8. PubMed ID: 18415697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.
    Vega GL; Cater NB; Hadizadeh DR; Meguro S; Grundy SM
    Clin Pharmacol Ther; 2003 Sep; 74(3):236-44. PubMed ID: 12966367
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased apolipoprotein A5 expression in human and rat non-alcoholic fatty livers.
    Feng Q; Baker SS; Liu W; Arbizu RA; Aljomah G; Khatib M; Nugent CA; Baker RD; Forte TM; Hu Y; Zhu L
    Pathology; 2015 Jun; 47(4):341-8. PubMed ID: 25938357
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apolipoprotein A5 T-1131C variant and risk for metabolic syndrome in obese adolescents.
    Zaki M; Amr K
    Gene; 2014 Jan; 534(1):44-7. PubMed ID: 24161374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dietary protein restriction reduces circulating VLDL triglyceride levels via CREBH-APOA5-dependent and -independent mechanisms.
    Treviño-Villarreal JH; Reynolds JS; Bartelt A; Langston PK; MacArthur MR; Arduini A; Tosti V; Veronese N; Bertozzi B; Brace LE; Mejia P; Trocha K; Kajitani GS; Longchamp A; Harputlugil E; Gathungu R; Bird SS; Bullock AD; Figenshau RS; Andriole GL; Thompson A; Heeren J; Ozaki CK; Kristal BS; Fontana L; Mitchell JR
    JCI Insight; 2018 Nov; 3(21):. PubMed ID: 30385734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proprotein convertase 7 (PCSK7) reduces apoA-V levels.
    Ashraf Y; Duval S; Sachan V; Essalmani R; Susan-Resiga D; Roubtsova A; Hamelin J; Gerhardy S; Kirchhofer D; Tagliabracci VS; Prat A; Kiss RS; Seidah NG
    FEBS J; 2020 Aug; 287(16):3565-3578. PubMed ID: 31945259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
    Qi L; Liu S; Rifai N; Hunter D; Hu FB
    Atherosclerosis; 2007 May; 192(1):204-10. PubMed ID: 16781717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipoprotein lipase activity does not predict very low-density lipoprotein-triglyceride fatty acid oxidation during exercise.
    Søndergaard E; Andersen IR; Sørensen LP; Gormsen LC; Nielsen S
    Scand J Med Sci Sports; 2017 May; 27(5):474-481. PubMed ID: 28207959
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Give me A5 for lipoprotein hydrolysis!
    Merkel M; Heeren J
    J Clin Invest; 2005 Oct; 115(10):2694-6. PubMed ID: 16200205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rare and common variants in LPL and APOA5 in Thai subjects with severe hypertriglyceridemia: A resequencing approach.
    Khovidhunkit W; Charoen S; Kiateprungvej A; Chartyingcharoen P; Muanpetch S; Plengpanich W
    J Clin Lipidol; 2016; 10(3):505-511.e1. PubMed ID: 27206937
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apolipoprotein A5 and hypertriglyceridemia in Prague hypertriglyceridemic rats.
    Kadlecová M; Hojná S; Bohuslavová R; Hubácek JA; Zicha J; Kunes J
    Physiol Res; 2006; 55(4):373-379. PubMed ID: 16238453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apolipoprotein A-V associates with intrahepatic lipid droplets and influences triglyceride accumulation.
    Shu X; Nelbach L; Ryan RO; Forte TM
    Biochim Biophys Acta; 2010 May; 1801(5):605-8. PubMed ID: 20153840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis B virus inhibits apolipoprotein A5 expression through its core gene.
    Zhu C; Gao G; Song H; Xu F; Wu K; Liu X
    Lipids Health Dis; 2016 Oct; 15(1):178. PubMed ID: 27724895
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A role for hepatic leptin signaling in lipid metabolism via altered very low density lipoprotein composition and liver lipase activity in mice.
    Huynh FK; Neumann UH; Wang Y; Rodrigues B; Kieffer TJ; Covey SD
    Hepatology; 2013 Feb; 57(2):543-54. PubMed ID: 22941940
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
    Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
    Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of triglyceride metabolism by glucocorticoids in diet-induced obesity.
    Mantha L; Palacios E; Deshaies Y
    Am J Physiol; 1999 Aug; 277(2):R455-64. PubMed ID: 10444552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.